Circulating metastasis associated in colon cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker

Table 1 Patients’ characteristics

	Primary diagnosis			Follow-up	All cancer patients
	W/o synchronous organ metastasis	With synchronous organ metastasis	With metachronous organ metastasis
Samples, n	9	8	5	54	76
AJCC/UICC I, %	67	0	80	48	47
T1-T2, N0, M0
T1, N1, M0
AJCC/UICC II, %	11	0	0	28	21
T1, N2, M0
T2, N1, M0
T3, N0, M0
AJCC/UICC III, %	11	0	20	24	20
T2, N2, M0
T3, N1, M0
T4, N0, M0
T3, N2, M0
AJCC/UICC IV, %	11	100	0	0	12
T4, N1-2, M0
Every T, N3, M0 every T, every N, M1
Median follow up, after blood taking (d)	677	351	169	851, 5	803
Age at blood taking, median (range) (yr)	63 (48-77)	59 (56-68)	71 (39-83)	63 (40-86)	63 (39-86)
Sex, m/f	8/1	7/1	4/1	38/16	57/19
P, vs tumor-free volunteers	P = 0.005	P = 0.002	P = 0.005	P = 0.021	P < 0.001

UICC: Union internationale contre le cancer; AJCC: American joint committee on cancer.